Federated Hermes, Inc. Moderna, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,250 shares of MRNA stock, worth $91,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,250

Previous 1,953 15.21%

Holding current value

$91,710

Previous $231,000 35.06%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $18,901 - $37,166	297 Added 15.21%	2,250 $150,000
Q2 2024 Aug 08, 2024	BUY	$101.21 - $166.61 $10,525 - $17,327	104 Added 5.62%	1,953 $231,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $426 - $577	-5 Reduced 0.27%	1,849 $197,000
Q4 2023 Jan 31, 2024	SELL	$69.51 - $104.43 $217,288 - $326,448	-3,126 Reduced 62.77%	1,854 $184,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $12,533 - $16,459	-130 Reduced 2.54%	4,980 $514,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $6.44 Million - $8.72 Million	-54,342 Reduced 91.4%	5,110 $620,000
Q1 2023 May 08, 2023	SELL	$135.66 - $197.02 $9.22 Million - $13.4 Million	-67,963 Reduced 53.34%	59,452 $9.13 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $5.07 Million - $8.99 Million	-42,798 Reduced 25.14%	127,415 $22.9 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $13.2 Million - $21.7 Million	111,644 Added 190.62%	170,213 $20.1 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $7.5 Million - $11.3 Million	-64,027 Reduced 52.23%	58,569 $8.37 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $15.1 Million - $28.1 Million	119,346 Added 3672.18%	122,596 $21.1 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $166 Million - $271 Million	-736,454 Reduced 99.56%	3,250 $826,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $178 Million - $389 Million	-803,480 Reduced 52.07%	739,704 $285 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $5.97 Million - $10.8 Million	-45,970 Reduced 2.89%	1,543,184 $363 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $28.8 Million - $49 Million	-263,727 Reduced 14.23%	1,589,154 $208 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $6.16 Million - $15.9 Million	93,688 Added 5.33%	1,852,881 $194 Million
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $97.5 Million - $170 Million	-1,794,611 Reduced 50.5%	1,759,193 $124 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $33.5 Million - $90.4 Million	-1,129,783 Reduced 24.12%	3,553,804 $228 Million
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $83.3 Million - $148 Million	4,682,416 Added 399864.72%	4,683,587 $140 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $16,312 - $24,918	1,171 New	1,171 $23,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Moderna, Inc. Transaction History